Clinical Trial Update: A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002 [Phase 3]

View source ↗

Summary

A Phase 3 randomized, unblinded trial comparing Zidovudine to ddC in patients with HIV infection who had long-term Zidovudine therapy after PCP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Zidovudine (Zidovudine)
• ddC (dideoxycytidine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED